MedTrace Logo

Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

NCT00828412 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-01-30

Study results available
· View outcomes & findings →

Summary

This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.

Conditions

Interventions

DEVICE

EpiCeram Skin Barrier Emulsion

topical cream, twice daily, 6 weeks

DRUG

Desonide Cream 0.05%

topical cream, twice daily, 6 weeks

Sponsors & Collaborators

  • Promius Pharma, LLC

    lead INDUSTRY

Principal Investigators

  • Joanne Fraser, PhD · Promius Pharma, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00828412 on ClinicalTrials.gov